ITPP Hexasodium 250 mg/ml
research-grade
solution
in a 20 ml glass bottle. Myo-inositol trispyrophosphate provided as its hexasodium salt, studied in laboratory models of hemoglobin oxygen affinity, tissue oxygenation and hypoxia-related research.
Research Use Only:
All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Purity
High-purity research grade
Content
250 mg ITPP Hexasodium per 1 ml; 20 ml per bottle (total 5,000 mg per bottle)
Packaging
20 ml glass bottle with sterile closure
Storage
Store at 2–8 °C, protect from light
Molecular formula
C₆H₆Na₆O₂₁P₆
Molecular weight
~821.84 g·mol⁻¹
IUPAC name
Hexasodium myo-inositol-1,3,5-tris(dihydrogen diphosphate)
Research Overview
ITPP Hexasodium (myo-inositol trispyrophosphate hexasodium salt) is a synthetic inositol phosphate derivative that acts as an allosteric effector of hemoglobin. In experimental models it is used to explore how modulation of hemoglobin’s oxygen affinity influences tissue oxygenation, hypoxia responses and performance-related physiology in controlled laboratory settings.
Primary Research Areas
-
Hemoglobin oxygen affinity modulation:
investigated as an allosteric effector of hemoglobin to study shifts in oxygen binding and release in red blood cells.
-
Tissue oxygenation and hypoxia models:
used in in vitro and in vivo research focused on improving or altering oxygen delivery in hypoxic and ischemic experimental conditions.
-
Exercise performance and endurance research:
explored in laboratory studies assessing oxygen utilization, metabolic responses and performance markers under controlled workloads.
-
Cardiovascular and microcirculatory models:
examined for its effects on blood flow, microvascular oxygen delivery and related cardiovascular endpoints in research settings.
-
Oxygen-transport and red blood cell biology:
used to probe mechanisms linking hemoglobin conformation, red blood cell function and systemic oxygen transport.
